| NDC Code: |
55390-134 |
| Proprietary Name: |
Cytarabine |
| Suffix: |
|
| Non-Proprietary Name: |
Cytarabine |
| Dosage Form: |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Method: |
INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS |
| Original Marketing Date: |
01-05-1996 |
| Category Name: |
ANDA |
| Application Number: |
ANDA074245 |
| Labeler: |
BEDFORD LABORATORIES |
| Substance Name: |
CYTARABINE |
| Active Numerator Strength: |
2 |
| Active Ingredient Unit: |
g/20mL |
| Pharm Classes: |
Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule: |
|
